CARDIOMINT Trademark

Trademark Overview

On Wednesday, November 17, 2021, a trademark application was filed for CARDIOMINT with the United States Patent and Trademark Office. The USPTO has given the CARDIOMINT trademark a serial number of 97130287. The federal status of this trademark filing is REGISTERED as of Tuesday, April 18, 2023. This trademark is owned by Stat Capsule Inc.. The CARDIOMINT trademark is filed in the Medical Instrument Products category with the following description:

Oral spray for medical purposes, namely, spray used to alleviate breathing difficulty and chest pain
cardiomint

General Information

Serial Number97130287
Word MarkCARDIOMINT
Filing DateWednesday, November 17, 2021
Status700 - REGISTERED
Status DateTuesday, April 18, 2023
Registration Number7032481
Registration DateTuesday, April 18, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2022

Trademark Statements

Pseudo MarkCARDIO MINT
Goods and ServicesOral spray for medical purposes, namely, spray used to alleviate breathing difficulty and chest pain

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, November 23, 2021
Primary Code010
First Use Anywhere DateSaturday, February 25, 2023
First Use In Commerce DateSaturday, February 25, 2023

Trademark Owner History

Party NameStat Capsule Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGlendale, CA 91205
Party NameStat Capsule Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGlendale, CA 91205
Party NameStat Capsule Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGlendale, CA 91205

Trademark Events

Event DateEvent Description
Tuesday, April 18, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 18, 2023REGISTERED-PRINCIPAL REGISTER
Friday, March 17, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, March 16, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, March 15, 2023STATEMENT OF USE PROCESSING COMPLETE
Saturday, February 25, 2023USE AMENDMENT FILED
Monday, March 13, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, February 25, 2023TEAS STATEMENT OF USE RECEIVED
Friday, February 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 22, 2023SOU EXTENSION 1 GRANTED
Wednesday, February 22, 2023SOU EXTENSION 1 FILED
Wednesday, February 22, 2023TEAS EXTENSION RECEIVED
Tuesday, August 23, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 28, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 28, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 8, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 18, 2022ASSIGNED TO LIE
Saturday, May 14, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 13, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 12, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 12, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 27, 2022NOTIFICATION OF PRIORITY ACTION E-MAILED
Wednesday, April 27, 2022PRIORITY ACTION E-MAILED
Wednesday, April 27, 2022PRIORITY ACTION WRITTEN
Friday, April 22, 2022ASSIGNED TO EXAMINER
Tuesday, November 23, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

cardiomint spray breathing difficulty pain alleviate chest used medical purposes namely